| Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma N Fujiwara, H Nakagawa, Y Kudo, R Tateishi, M Taguri, T Watadani, ... Journal of hepatology 63 (1), 131-140, 2015 | 636 | 2015 |
| CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity N Fujiwara, H Nakagawa, K Enooku, Y Kudo, Y Hayata, T Nakatsuka, ... Gut 67 (8), 1493-1504, 2018 | 157 | 2018 |
| Blocking CXCLs–CXCR2 axis in tumor–stromal interactions contributes to survival in a mouse model of pancreatic ductal adenocarcinoma through reduced cell … M Sano, H Ijichi, R Takahashi, K Miyabayashi, H Fujiwara, T Yamada, ... Oncogenesis 8 (2), 8, 2019 | 79 | 2019 |
| Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer K Yamamoto, K Tateishi, Y Kudo, M Hoshikawa, M Tanaka, T Nakatsuka, ... Oncotarget 7 (38), 61469, 2016 | 77 | 2016 |
| Histone demethylase KDM4C regulates sphere formation by mediating the cross talk between Wnt and Notch pathways in colonic cancer cells S Yamamoto, K Tateishi, Y Kudo, K Yamamoto, T Isagawa, G Nagae, ... Carcinogenesis 34 (10), 2380-2388, 2013 | 54 | 2013 |
| Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis S Kawamura, Y Matsushita, S Kurosaki, M Tange, N Fujiwara, Y Hayata, ... The Journal of clinical investigation 132 (11), 2022 | 43 | 2022 |
| Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism M Sano, R Takahashi, H Ijichi, K Ishigaki, T Yamada, K Miyabayashi, ... Gut 70 (9), 1713-1723, 2021 | 40 | 2021 |
| Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation T Nakatsuka, K Tateishi, Y Kudo, K Yamamoto, H Nakagawa, H Fujiwara, ... Oncogene 36 (45), 6262-6271, 2017 | 40 | 2017 |
| Sharpin promotes hepatocellular carcinoma progression via transactivation of Versican expression Y Tanaka, K Tateishi, T Nakatsuka, Y Kudo, R Takahashi, K Miyabayashi, ... Oncogenesis 5 (12), e277-e277, 2016 | 36 | 2016 |
| Changing clinical management of NAFLD in Asia T Nakatsuka, R Tateishi, K Koike Liver International 42 (9), 1955-1968, 2022 | 28 | 2022 |
| Mutant IDH1 confers resistance to energy stress in normal biliary cells through PFKP-induced aerobic glycolysis and AMPK activation H Fujiwara, K Tateishi, K Misumi, A Hayashi, K Igarashi, H Kato, ... Scientific reports 9 (1), 18859, 2019 | 25 | 2019 |
| MNX1-HNF1B axis is indispensable for intraductal papillary mucinous neoplasm lineages H Kato, K Tateishi, H Fujiwara, T Nakatsuka, K Yamamoto, Y Kudo, ... Gastroenterology 162 (4), 1272-1287. e16, 2022 | 24 | 2022 |
| Impact of obesity and heavy alcohol consumption on hepatocellular carcinoma development after HCV eradication with antivirals T Minami, R Tateishi, N Fujiwara, R Nakagomi, T Nakatsuka, M Sato, ... Liver cancer 10 (4), 309-319, 2021 | 20 | 2021 |
| Inhibition of histone methyltransferase G9a attenuates liver cancer initiation by sensitizing DNA-damaged hepatocytes to p53-induced apoptosis T Nakatsuka, K Tateishi, H Kato, H Fujiwara, K Yamamoto, Y Kudo, ... Cell Death & Disease 12 (1), 99, 2021 | 19 | 2021 |
| Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ 1 H Fujiwara, K Tateishi, H Kato, T Nakatsuka, K Yamamoto, Y Tanaka, ... Cancer Science 109 (11), 3602-3610, 2018 | 19 | 2018 |
| Cell fate analysis of zone 3 hepatocytes in liver injury and tumorigenesis S Kurosaki, H Nakagawa, Y Hayata, S Kawamura, Y Matsushita, ... JHEP Reports 3 (4), 100315, 2021 | 17 | 2021 |
| Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer R Takahashi, H Ijichi, M Sano, K Miyabayashi, D Mohri, J Kim, G Kimura, ... Scientific Reports 10 (1), 21194, 2020 | 17 | 2020 |
| Development and prognosis of hepatocellular carcinoma in patients with diabetes T Nakatsuka, R Tateishi Clinical and Molecular Hepatology 29 (1), 51, 2023 | 16 | 2023 |
| Development of novel deep multimodal representation learning‐based model for the differentiation of liver tumors on B‐mode ultrasound images M Sato, T Kobayashi, Y Soroida, T Tanaka, T Nakatsuka, H Nakagawa, ... Journal of Gastroenterology and Hepatology 37 (4), 678-684, 2022 | 15 | 2022 |
| Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma T Nakatsuka, H Nakagawa, Y Hayata, T Wake, T Yamada, ... Journal of Gastroenterology 56, 456-469, 2021 | 13 | 2021 |
